Medtronic plc announced first enrollments in a new clinical trial evaluating the ECG (electrocardiography) Belt Research System (ECG Belt) as a diagnostic tool for optimizing cardiac resynchronization...
Companion Medical, a leader in the development of advanced technology to improve diabetes care, has received CE mark for the InPen system, paving the way for...
PTC Therapeutics, Inc. announced that it has entered into an agreement to acquire Agilis Biotherapeutics, Inc., a biotechnology company advancing an innovative gene therapy platform for...
Hill-Rom Holdings, Inc., is changing the start time of its fiscal third quarter 2018 earnings conference call and webcast on Friday, July 27, 2018, to 7:00...
Merck, known as MSD outside the United States and Canada, has a long history of responsible pricing. In 2017, Merck issued its second annual Pricing Action...
CARMELINA (CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 diabetes at high vascular risk) met its primary endpoint, defined as time to...
Bristol-Myers Squibb Company and Gritstone Oncologytoday announced that the companies have entered into a clinical trial collaboration to evaluate the safety and tolerability of Gritstone’s personalized...
Researchers have discovered a key link to potentially understanding sleep disorders in children, according to a study just published in the journal PLOS One. In a...
On 18 July, the FDA unveiled the Biosimilar Action Plan (BAP), which aims to promote the development and accessibility of biosimilars in the US healthcare market....
Johnson & Johnson Innovation LLC today announced agreement to launch the Johnson & Johnson Innovation, JLABS (JLABS) JPOD @ Philadelphia (JPOD @ Philadelphia) in collaboration with the University of Pennsylvania (Penn)...
Olympus, a global technology leader for digital voice recorders, has launched a new generation of mobile dictation devices, has launched a new generation of mobile dictation...
Baxter International Inc., a leading global medical products company, announced that its Board of Directors has declared a quarterly cash dividend of USD 0.19 per share...
Novartis announced that it has entered into an exclusive license agreement with biotech companies Galapagos NV, Mechelen (Belgium) and MorphoSys AG, Planegg/Munich (Germany) regarding their compound...
Bausch Health Companies Inc. will release its second-quarter 2018 financial results on Tuesday, Aug. 7, 2018. Bausch Health will host a conference call and live web cast...
Hill-Rom Holdings, Inc. announced that its board of directors declared a fiscal 2018 fourth quarter dividend of USD 0.20 per share payable on September 28, 2018, to shareholders of record as...
Copyright © 2024 Medical Buyer